Prof. Caicai Xi | Cardiovascular Researches | Best Researcher Award

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | China

Prof. Caicai Xi is a postdoctoral fellow at the College of Life Sciences, Zhejiang University, and holds a doctoral degree from Nanjing University of Chinese Medicine. Her research expertise lies in the total synthesis, extraction, separation, and biological evaluation of natural products derived from traditional Chinese medicine (TCM). She has also made significant contributions to the fields of production and synthetic biology of TCM resources, pharmacological and active material basis studies of TCM compound serum, and the development of hospital preparations and new drug formulations. Prof. Xi’s research aims to promote the rational utilization, modernization, and industrial application of TCM resources through scientific innovation and interdisciplinary integration. She has published 15 academic papers, which have collectively received 137 citations, and her work is reflected in an h-index of 3, indicating a growing academic impact in her area of specialization. Beyond her research publications, Prof. Xi has presided over and participated in 11 scientific research projects, contributed to the drafting of one technical standard, and co-authored one academic monograph. Recognized as a High-level Talent (Class E) in Zhejiang Province and Hangzhou City, she also holds positions in national professional organizations dedicated to TCM research and innovation. Her active participation in these scientific communities underscores her commitment to advancing the modernization and global relevance of traditional Chinese medicine through innovative research and collaborative development.

Profile: Scopus

Featured Publication

Wu, R., Wang, J., Zhou, H., Xue, X., Tong, C., Zhao, L., Wu, Y., Mei, X., Guo, Z., & Xi, C. (2025). Analysis of blood components and target prediction for the combined use of Dendrobium officinale compound and Western medicine in antihypertensive therapy based on network pharmacology and molecular docking. Drug Design, Development and Therapy

Caicai Xi | Cardiovascular Researches | Best Researcher Award

You May Also Like